Company / Current Assets
Harmony Biosciences Holdings, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$907.0M
FY2025
5-year range
$284.4M / $907.0M
FY2021-FY2025
Trend
+56.6%
vs FY2024
Sector context
#59 of 213
Health Care
What the data says
At $907M, Harmony Biosciences Holdings, Inc.'s current assets ranks #59 of 213 in the Health Care sector. Current Assets has increased for 6 consecutive years, from $31M in FY2019 to $907M in FY2025.
Based on SEC 10-K filings.
$907M in FY2025 with a 5-year CAGR of +28.1%.
Improved from $451M to $907M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +31.3%
- 5-Year CAGR
- +28.1%
- 10-Year CAGR
- -
Sector benchmark
#59 of 213 in Health CareTop 28% of 213This company $907.0M Sector average $2.5B
▼
-64.0% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s current assets has grown for 6 consecutive years.
- 5-year CAGR of +28.1%, indicating consistent growth.
- In FY2025, current assets increased 56.6% year-over-year.
- Ranks #59 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $907.0M | +56.6% |
| FY2024 | $579.3M | +28.4% |
| FY2023 | $451.1M | +12.7% |
| FY2022 | $400.3M | +40.7% |
| FY2021 | $284.4M | +8.2% |
| FY2020 | $262.9M | +734.7% |
| FY2019 | $31.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026